Krystal Biotech Inc (KRYS)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

2100 WHARTON STREET PITTSBURGH, PA 15203

Krystal Biotech, Inc. is a pivotal-stage gene therapy company leveraging its novel, redosable gene therapy platform and in-house manufacturing capabilities to develop therapies to treat serious rare diseases.

Data as of 2021-09-19 13:10:11 -0400
Market Cap1.314 Billion Shares Outstanding22.206 Million Avg 30-day Volume100.851 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.48725 52-week High/Low87.29 / 40.04 Next Earnings Date2021-11-05 Price to Cash FLow (P/CF) -92.3154
Data provided by IEX Cloud
View SEC Filings from KRYS instead.

View recent insider trading info

Krystal Biotech Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding KRYS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding KRYS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

JANNEY DANIEL

  • Director
 6,800 2021-06-30 1

ROSSI DINO A

  • Director
 6,800 2021-06-30 1

GANGOLLI JULIAN S

  • Director
 6,800 2021-06-30 1

MARANTZ JING L.

  • Director
 6,800 2021-06-30 3

MASON CHRISTOPHER

  • Director
 6,800 2021-06-30 3

ORTH ANDREW C. CHIEF COMMERCIAL OFFICER

  • Officer
 205,100 2021-05-31 2

KRISHNAN KRISH S PRESIDENT AND CEO

  • Officer
  • Director
  • 10% Owner
 3,965,088 2021-02-26 1

KRISHNAN SUMA CHIEF OPERATING OFFICER

  • Officer
  • Director
  • 10% Owner
 3,946,488 2021-02-26 1

ROMANO KATHRYN CHIEF ACCOUNTING OFFICER

  • Officer
 49,000 2021-02-26 1

CHIEN JENNIFER CHIEF COMMERCIAL OFFICER

  • Officer
 0 2020-01-31 0

RILEY ANTONY A CHIEF FINANCIAL OFFICER

  • Officer
 9,050 2019-11-19 0

NORBY R DOUGLAS

  • Director
 0 2018-05-31 0

SUN PHARMA (NETHERLANDS) B.V.

  • 10% Owner
 0 2017-09-19 0

GANORKAR KIRTI

  • Director
 0 2017-09-19 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
KRYSTAL BIOTECH INC KRYS 2021-09-23 22:15:03 UTC -0.1974 0.2674 500000
KRYSTAL BIOTECH INC KRYS 2021-09-23 21:45:03 UTC -0.1974 0.2674 500000
KRYSTAL BIOTECH INC KRYS 2021-09-23 21:15:03 UTC -0.1974 0.2674 500000
KRYSTAL BIOTECH INC KRYS 2021-09-23 20:45:03 UTC -0.1974 0.2674 500000
KRYSTAL BIOTECH INC KRYS 2021-09-23 20:15:03 UTC -0.1974 0.2674 500000
KRYSTAL BIOTECH INC KRYS 2021-09-23 19:45:03 UTC -0.1974 0.2674 500000
KRYSTAL BIOTECH INC KRYS 2021-09-23 19:15:03 UTC -0.1974 0.2674 500000
KRYSTAL BIOTECH INC KRYS 2021-09-23 18:45:04 UTC -0.1974 0.2674 500000
KRYSTAL BIOTECH INC KRYS 2021-09-23 18:15:03 UTC -0.1974 0.2674 500000
KRYSTAL BIOTECH INC KRYS 2021-09-23 17:45:03 UTC -0.1974 0.2674 500000
KRYSTAL BIOTECH INC KRYS 2021-09-23 17:15:03 UTC -0.1974 0.2674 500000
KRYSTAL BIOTECH INC KRYS 2021-09-23 16:45:03 UTC -0.185 0.255 500000
KRYSTAL BIOTECH INC KRYS 2021-09-23 16:15:03 UTC -0.185 0.255 500000
KRYSTAL BIOTECH INC KRYS 2021-09-23 15:45:03 UTC -0.185 0.255 500000
KRYSTAL BIOTECH INC KRYS 2021-09-23 15:15:03 UTC -0.185 0.255 500000
KRYSTAL BIOTECH INC KRYS 2021-09-23 14:45:03 UTC -0.185 0.255 500000
KRYSTAL BIOTECH INC KRYS 2021-09-23 14:15:03 UTC -0.185 0.255 500000
KRYSTAL BIOTECH INC KRYS 2021-09-23 13:45:03 UTC -0.185 0.255 500000
KRYSTAL BIOTECH INC KRYS 2021-09-23 13:15:03 UTC -0.185 0.255 500000
KRYSTAL BIOTECH INC KRYS 2021-09-23 12:45:03 UTC -0.185 0.255 500000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
AQR Funds- AQR Small Cap Relaxed Constraint Equity Fund KRYS -28.0 shares, $-972.3 2019-09-30 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund KRYS -8.0 shares, $-345.92 2020-03-31 N-PORT
Weiss Strategic Interval Fund- Weiss Strategic Interval Fund KRYS -1076.0 shares, $-73168.0 2021-06-30 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund KRYS -500.0 shares, $-34000.0 2021-06-30 N-PORT

Elevate your investments